AbbVie Inc. ABBVAbbVie, Inc.BATS:ABBVMehran90NS**AbbVie Inc.** is a global biopharmaceutical company focused on innovative medicines across immunology, oncology, neuroscience, eye care, and aesthetics. Its diversified portfolio, established commercial presence, and continued investment in research and development provide a foundation for long-term growth across multiple healthcare markets. The broader technical picture remains constructive, but the lower timeframe requires additional confirmation before the next upward phase can be considered fully established. The key focus at this stage is whether buyers can regain control and develop a sustained bullish structure. A combination of renewed buyer participation and improving price action would provide stronger evidence that the stock is preparing for further growth. **Key technical observations:** • The higher-timeframe structure remains the primary reference for evaluating the current bullish outlook. • On the lower timeframe, investors should monitor for the formation of **Higher Highs (HH)** and **Higher Lows (HL)** as evidence that buyers are rebuilding market control. • Increasing buyer participation around important support areas would strengthen the probability of a continuation move. • A constructive shift in the moving averages could provide additional confirmation that short-term momentum is aligning with the broader bullish structure. Technical analysis can help identify when market structure is improving, but the long-term investment case should also be supported by fundamental analysis. Combining price action with DCF, FCFF, FCFE, and intrinsic value assessment can provide a more complete framework for evaluating AbbVie's long-term potential. A strong technical setup is generally more meaningful when demand begins to appear alongside an intact underlying trend. Patience, confirmation of buyer participation, and disciplined risk management remain important when evaluating whether the current structure can develop into a sustained advance. This publication reflects a personal interpretation of market structure and publicly available information. It is intended solely for educational and informational purposes and should not be considered financial advice or a recommendation to buy, sell, or hold any financial instrument. Independent research, prudent risk management, and personal due diligence should always precede any investment decision.